Programmed Death Ligand-1 (PD-L1) Expression in Patients with Non-Small Cell Lung Cancer (NSCLC) with Unusual Metastasis: A Case Series

被引：0
|
作者：
Tsugitomi, R. [1 ]
Nishimura, N. [1 ]
Imai, R. [1 ]
Okafuji, K. [1 ]
Kitamura, A. [1 ]
Tomishima, Y. [1 ]
Jinta, T. [1 ]
Suzuki, K. [2 ]
Tamura, T. [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, Tokyo, Japan
[2] St Lukes Int Hosp, Dept Pathol, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3940
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [2] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)
    McLaughlin, Joseph
    Schalper, Kurt A.
    Carvajal-Hausdorf, Daniel E.
    Pelekanou, Vasiliki
    Velcheti, Vamsidhar
    Haack, Herbert
    Silver, Matthew R.
    Herbst, Roy
    LoRusso, Patricia
    Rimm, David L.
    CANCER RESEARCH, 2015, 75
  • [4] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Artem
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2016, 96 : 467A - 467A
  • [5] Programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC), results of a single institution
    Slezak, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S112 - S112
  • [6] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Arteni
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    MODERN PATHOLOGY, 2016, 29 : 467A - 467A
  • [7] Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
    Valcarcel Gonzalez, S.
    Diaz, P.
    Villanueva Palicio, N.
    Alvarez Fernandez, C.
    Contreras Toledo, D. C.
    Mihic Gongora, L.
    Rodriguez Gonzalez, A.
    Velasco Durantez, V.
    Solis Hernandez, M. D. P.
    Esteban Gonzalez, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S569 - S570
  • [8] Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    D'Arcangelo, M.
    Puccetti, M.
    Bravaccini, S.
    D'Incecco, A.
    Ligorio, C.
    Terracciano, L.
    Damiani, S.
    Ravaioli, S.
    Tumedei, M. M.
    Bennati, C.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Incarbone, M.
    Milesi, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [9] The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
    Skov, Birgit Guldhammer
    Rorvig, Sara Bird
    Jensen, Thomas Hartvig Lindkaer
    Skov, Torsten
    MODERN PATHOLOGY, 2020, 33 (01) : 109 - 117
  • [10] Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mino-Kenudson, Mari
    CANCER BIOLOGY & MEDICINE, 2016, 13 (02) : 157 - 170
12345